S100A7 and lung cancer: However, accumulating evidence suggested that S100A7 was negatively correlated with immune infiltration and immunomodulators in the lung cancer, for instance, expression of S100A7 could inhibit PD-L1, leading to down-regulating CD68+ macrophage infiltration [36].